Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil vs fentanyl for interventional surgery in lower extremity arteriosclerosis obliterans
ChiCTR2100054991Phase 4Recruiting
- Sponsor
- Xiamen Cardiovascular Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alfentanil in arteriosclerosis obliterans (2 arms), sponsored by Xiamen Cardiovascular Hospital. Primary endpoint: Incidence of intraoperative hypoxemia. Started Dec 2021; status: recruiting.
02
Drugs
alfentanil
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on ChiCTR2100054991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054991.